Basis: Latest stored market observation. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the Price/OCF ratio high or low?
The Price/OCF ratio of 8.05 is in line with its 5-year average of 8.45, near the low end of its 5-year range (6.14–28.75).
As of Wednesday, September 2, 2026. 4.23% below its 12-month average of 8.41.
PRICE/OCF RATIO
8.05
PRICE/OCF RATIO AVG TTM
8.41
PRICE/OCF RATIO AVG 3Y
8.56
PRICE/OCF RATIO AVG 5Y
8.45
PRICE/OCF RATIO AVG 10Y
7.20
PRICE/OCF RATIO AVG 15Y
6.65
PRICE/OCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-4.23%
CURRENT VS 3Y AVG
-5.93%
CURRENT VS 5Y AVG
-4.78%
CURRENT VS 10Y AVG
+11.75%
CURRENT VS 15Y AVG
+21.00%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
16.42
median of 83 covered companies
CURRENT VS SECTOR MEDIAN
-50.97%
vs the sector median at left
Market Cap
$89.83B
Price/OCF Ratio
11.85
TTM Avg
13.61
3Y Avg
22.70
5Y Avg
18.29
Market Cap
$86.58B
Price/OCF Ratio
20.48
TTM Avg
15.37
3Y Avg
19.11
5Y Avg
17.40
Market Cap
$108.09B
Price/OCF Ratio
16.09
TTM Avg
13.98
3Y Avg
16.65
5Y Avg
14.02
Market Cap
$69.93B
Price/OCF Ratio
15.86
TTM Avg
24.88
3Y Avg
36.19
5Y Avg
37.92
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HCA Healthcare, Inc. (HCA) | $89.02B | 8.05 | 8.41 | 8.56 | 8.45 |
| Elevance Health Inc. (ELV)vs › | $89.83B | 11.85 | 13.61 | 22.70 | 18.29 |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $86.58B | 20.48 | 15.37 | 19.11 | 17.40 |
| GSK plc (GSK)vs › | $101.75B | 8.77 | 9.26 | 9.25 | 8.47 |
| Cigna Corporation (CI)vs › | $75.27B | 7.26 | 9.34 | 9.63 | 9.63 |
| Sanofi (SNY)vs › | $106.39B | 6.42 | 6.38 | 6.38 | 6.38 |
| McKesson Corporation (MCK)vs › | $108.09B | 16.09 | 13.98 | 16.65 | 14.02 |
| Boston Scientific Corporation (BSX)vs › | $69.93B | 15.86 | 24.88 | 36.19 | 37.92 |
| Cencora, Inc. (COR)vs › | $65.47B | 13.53 | 22.70 | 17.01 | 14.66 |
| Stryker Corporation (SYK)vs › | $118.30B | 21.81 | 26.61 | 33.05 | 32.99 |
P/OCF Ratio
8.1
P/FCF Ratio
14.9
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/OCF RATIO |
|---|---|
| 2026-09-02 | 8.05 |
| 2026-09-01 | 8.28 |
| 2026-08-31 | 8.30 |
| 2026-08-28 | 8.37 |
| 2026-08-27 | 8.40 |
| 2026-08-26 | 8.56 |
| 2026-08-25 | 8.59 |
| 2026-08-24 | 8.60 |
| 2026-08-21 | 8.60 |
| 2026-08-20 | 8.14 |
| 2026-08-19 | 8.15 |
| 2026-08-18 | 8.25 |
| 2026-08-17 | 8.11 |
| 2026-08-14 | 8.11 |
| 2026-08-13 | 8.25 |
| 2026-08-12 | 8.30 |
| 2026-08-11 | 8.24 |
| 2026-08-10 | 8.29 |
| 2026-08-07 | 8.28 |
| 2026-08-06 | 8.19 |
| 2026-08-05 | 8.21 |
| 2026-08-04 | 8.03 |
| 2026-08-03 | 8.14 |
| 2026-07-31 | 8.06 |
| 2026-07-30 | 7.93 |
| 2026-07-29 | 8.18 |
| 2026-07-28 | 8.38 |
| 2026-07-27 | 6.79 |
| 2026-07-24 | 6.66 |
| 2026-07-23 | 6.56 |
| 2026-07-22 | 6.48 |
| 2026-07-21 | 6.51 |
| 2026-07-20 | 6.46 |
| 2026-07-17 | 6.47 |
| 2026-07-16 | 6.73 |
| 2026-07-15 | 6.61 |
| 2026-07-14 | 6.34 |
| 2026-07-13 | 6.81 |
| 2026-07-10 | 7.09 |
| 2026-07-09 | 7.13 |
| 2026-07-08 | 7.16 |
| 2026-07-07 | 7.38 |
| 2026-07-06 | 7.27 |
| 2026-07-02 | 7.16 |
| 2026-07-01 | 6.86 |
| 2026-06-30 | 6.80 |
| 2026-06-29 | 6.84 |
| 2026-06-26 | 6.83 |
| 2026-06-25 | 6.75 |
| 2026-06-24 | 6.76 |
| 2026-06-23 | 6.75 |
| 2026-06-22 | 6.57 |
| 2026-06-18 | 6.54 |
| 2026-06-17 | 6.77 |
| 2026-06-16 | 6.92 |
| 2026-06-15 | 6.80 |
| 2026-06-12 | 6.75 |
| 2026-06-11 | 6.60 |
| 2026-06-10 | 6.51 |
| 2026-06-09 | 6.54 |
| 2026-06-08 | 6.30 |
| 2026-06-05 | 6.49 |
| 2026-06-04 | 6.31 |
| 2026-06-03 | 6.33 |
| 2026-06-02 | 6.41 |
| 2026-06-01 | 6.47 |
| 2026-05-29 | 6.60 |
| 2026-05-28 | 6.70 |
| 2026-05-27 | 6.84 |
| 2026-05-26 | 6.84 |
| 2026-05-22 | 6.87 |
| 2026-05-21 | 6.84 |
| 2026-05-20 | 6.92 |
| 2026-05-19 | 7.06 |
| 2026-05-18 | 7.37 |
| 2026-05-15 | 7.38 |
| 2026-05-14 | 7.54 |
| 2026-05-13 | 7.45 |
| 2026-05-12 | 7.49 |
| 2026-05-11 | 7.43 |
| 2026-05-08 | 7.59 |
| 2026-05-07 | 7.48 |
| 2026-05-06 | 7.49 |
| 2026-05-05 | 7.48 |
| 2026-05-04 | 7.45 |
| 2026-05-01 | 7.55 |
| 2026-04-30 | 7.58 |
| 2026-04-29 | 7.58 |
| 2026-04-28 | 7.89 |
| 2026-04-27 | 8.14 |
| 2026-04-24 | 7.90 |
| 2026-04-23 | 8.65 |
| 2026-04-22 | 8.61 |
| 2026-04-21 | 8.60 |
| 2026-04-20 | 8.73 |
| 2026-04-17 | 8.91 |
| 2026-04-16 | 8.82 |
| 2026-04-15 | 8.92 |
| 2026-04-14 | 9.10 |
| 2026-04-13 | 9.08 |
| 2026-04-10 | 9.05 |
| 2026-04-09 | 9.26 |
| 2026-04-08 | 9.22 |
| 2026-04-07 | 8.94 |
| 2026-04-06 | 8.84 |
| 2026-04-02 | 8.61 |
| 2026-04-01 | 8.67 |
| 2026-03-31 | 8.64 |
| 2026-03-30 | 8.54 |
| 2026-03-27 | 8.62 |
| 2026-03-26 | 8.77 |
| 2026-03-25 | 8.84 |
| 2026-03-24 | 8.87 |
| 2026-03-23 | 9.03 |
| 2026-03-20 | 9.02 |
| 2026-03-19 | 9.12 |
| 2026-03-18 | 9.17 |
| 2026-03-17 | 9.31 |
| 2026-03-16 | 9.59 |
| 2026-03-13 | 9.73 |
| 2026-03-12 | 9.72 |
| 2026-03-11 | 9.81 |
| 2026-03-10 | 9.82 |
| 2026-03-09 | 9.95 |
| 2026-03-06 | 9.73 |
| 2026-03-05 | 9.76 |
| 2026-03-04 | 9.94 |
| 2026-03-03 | 9.89 |
| 2026-03-02 | 9.73 |
| 2026-02-27 | 9.67 |
| 2026-02-26 | 9.60 |
| 2026-02-25 | 9.87 |
| 2026-02-24 | 9.61 |
| 2026-02-23 | 9.79 |
| 2026-02-20 | 9.72 |
| 2026-02-19 | 9.65 |
| 2026-02-18 | 9.77 |
| 2026-02-17 | 9.76 |
| 2026-02-13 | 9.86 |
| 2026-02-12 | 9.77 |
| 2026-02-11 | 9.70 |
| 2026-02-10 | 9.16 |
| 2026-02-09 | 9.40 |
| 2026-02-06 | 9.48 |
| 2026-02-05 | 9.70 |
| 2026-02-04 | 9.32 |
| 2026-02-03 | 9.43 |
| 2026-02-02 | 9.38 |
| 2026-01-30 | 9.22 |
| 2026-01-29 | 9.11 |
| 2026-01-28 | 9.28 |
| 2026-01-27 | 9.55 |
| 2026-01-26 | 8.92 |
| 2026-01-23 | 8.89 |
| 2026-01-22 | 8.81 |
| 2026-01-21 | 8.79 |
| 2026-01-20 | 8.77 |
| 2026-01-16 | 8.86 |
| 2026-01-15 | 9.14 |
| 2026-01-14 | 9.04 |
| 2026-01-13 | 9.05 |
| 2026-01-12 | 8.96 |
| 2026-01-09 | 8.92 |
| 2026-01-08 | 9.05 |
| 2026-01-07 | 8.89 |
| 2026-01-06 | 9.13 |
| 2026-01-05 | 9.03 |
| 2026-01-02 | 8.89 |
| 2025-12-31 | 8.82 |
| 2025-12-30 | 8.94 |
| 2025-12-29 | 8.95 |
| 2025-12-26 | 9.01 |
| 2025-12-24 | 8.95 |
| 2025-12-23 | 8.95 |
| 2025-12-22 | 8.92 |
| 2025-12-19 | 8.93 |
| 2025-12-18 | 8.81 |
| 2025-12-17 | 8.91 |
| 2025-12-16 | 8.87 |
| 2025-12-15 | 9.01 |
| 2025-12-12 | 9.16 |
| 2025-12-11 | 9.11 |
| 2025-12-10 | 8.85 |
| 2025-12-09 | 9.23 |
| 2025-12-08 | 9.16 |
| 2025-12-05 | 9.19 |
| 2025-12-04 | 9.21 |
| 2025-12-03 | 9.19 |
| 2025-12-02 | 9.45 |
| 2025-12-01 | 9.50 |
| 2025-11-28 | 9.60 |
| 2025-11-26 | 9.72 |
| 2025-11-25 | 9.74 |
| 2025-11-24 | 9.46 |
| 2025-11-21 | 9.27 |
| 2025-11-20 | 9.00 |
| 2025-11-19 | 9.09 |
| 2025-11-18 | 9.03 |
| 2025-11-17 | 9.01 |
| 2025-11-14 | 8.93 |
| 2025-11-13 | 8.94 |
| 2025-11-12 | 8.95 |
| 2025-11-11 | 8.73 |
| 2025-11-10 | 8.68 |
| 2025-11-07 | 9.00 |
| 2025-11-06 | 8.90 |
| 2025-11-05 | 8.94 |
| 2025-11-04 | 8.91 |
| 2025-11-03 | 8.72 |
| 2025-10-31 | 8.68 |
| 2025-10-30 | 8.82 |
| 2025-10-29 | 9.49 |
| 2025-10-28 | 9.45 |
| 2025-10-27 | 9.48 |
| 2025-10-24 | 9.06 |
| 2025-10-23 | 8.92 |
| 2025-10-22 | 8.94 |
| 2025-10-21 | 8.76 |
| 2025-10-20 | 8.78 |
| 2025-10-17 | 8.64 |
| 2025-10-16 | 8.50 |
| 2025-10-15 | 8.52 |
| 2025-10-14 | 8.48 |
| 2025-10-13 | 8.32 |
| 2025-10-10 | 8.41 |
| 2025-10-09 | 8.49 |
| 2025-10-08 | 8.64 |
| 2025-10-07 | 8.87 |
| 2025-10-06 | 8.79 |
| 2025-10-03 | 8.71 |
| 2025-10-02 | 8.65 |
| 2025-10-01 | 8.64 |
| 2025-09-30 | 8.64 |
| 2025-09-29 | 8.53 |
| 2025-09-26 | 8.49 |
| 2025-09-25 | 8.41 |
| 2025-09-24 | 8.44 |
| 2025-09-23 | 8.30 |
| 2025-09-22 | 8.25 |
| 2025-09-19 | 8.15 |
| 2025-09-18 | 8.13 |
| 2025-09-17 | 8.10 |
| 2025-09-16 | 8.10 |
| 2025-09-15 | 8.17 |
| 2025-09-12 | 8.21 |
| 2025-09-11 | 8.17 |
| 2025-09-10 | 7.99 |
| 2025-09-09 | 8.38 |
| 2025-09-08 | 8.47 |
| 2025-09-05 | 8.53 |
| 2025-09-04 | 8.34 |
| 2025-09-03 | 8.26 |
| 2025-09-02 | 8.23 |
| 2025-08-29 | 8.19 |
| 2025-08-28 | 8.26 |
| 2025-08-27 | 8.21 |
| 2025-08-26 | 8.15 |
| 2025-08-25 | 8.16 |
| 2025-08-22 | 8.21 |
| 2025-08-21 | 8.19 |
Showing the most recent 260 of 3,894 data points. The chart above shows the full history.
